Company / AR per Share
Edwards Lifesciences AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$1.14
FY2025
5-year range
$0.93 / $1.27
FY2021-FY2025
Trend
+12.1%
vs FY2024
Sector context
#103 of 136
Health Care
What the data says
Edwards Lifesciences's ar per share of $1.14 is lower than 76% of companies in the Health Care sector (FY2025). AR per Share has fluctuated over the past 10 years, ranging from $0.82 in FY2020 to $2.60 in FY2019.
Based on SEC 10-K filings.
1.14 in FY2025 with a 5-year CAGR of +6.6%.
Declined from $1.27 to $1.14 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +2.4%
- 5-Year CAGR
- +6.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 136This company $1.14 Sector average $12.05
▼
-90.6% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 12.1% year-over-year.
- Ranks #103 out of 136 companies in the Health Care sector.
- Peak ar per share was recorded in FY2019.
- Lowest ar per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.14 | +12.1% |
| FY2024 | $1.01 | -20.5% |
| FY2023 | $1.27 | +20.5% |
| FY2022 | $1.06 | +13.3% |
| FY2021 | $0.93 | +13.2% |
| FY2020 | $0.82 | -68.3% |
| FY2019 | $2.60 | +18.2% |
| FY2018 | $2.20 | +6.1% |
| FY2017 | $2.07 | +20.0% |
| FY2016 | $1.73 | -41.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026